iShares Nasdaq Biotechnology (IBB) puts after Biogen (BIIB) discontinues two Alzheimer's trials
Go back to iShares Nasdaq Biotechnology (IBB) puts after Biogen (BIIB) discontinues two Alzheimer's trials| iShares Nasdaq Biotechnology Index Fund (NASDAQ: IBB) | Delayed: 210.82 +1.77 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $209.05 | 52 Week High | $343.87 | |||
| Open | $208.74 | 52 Week Low | $240.03 | |||
| Day High | $211.24 | P/E | N/A | |||
| Day Low | $208.47 | EPS | $0.00 | |||
| Volume | 1,566,986 | |||||
